{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T09:46:10Z","timestamp":1758620770130,"version":"3.44.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004612","name":"Funda\u00e7\u00e3o Arauc\u00e1ria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bioorg.2023.106835","type":"journal-article","created":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T01:18:39Z","timestamp":1693703919000},"page":"106835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Two-dimensional chromatography for enantiomeric analysis of mitotane and its metabolite o,p\u2032-DDA in patients with adrenocortical carcinoma indicates enantioselective metabolism"],"prefix":"10.1016","volume":"141","author":[{"given":"Gabriela","family":"Stadler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"de Almeida Veiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Rita Corso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila","family":"Bach de Assis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"de Toledo Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Regina Rocha Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Cruz Bonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1via","family":"Lada Degaut Pontes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonald","family":"Cavalcante de Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauro","family":"Mera de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bioorg.2023.106835_b0005","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/1097-0142(19931201)72:11<3145::AID-CNCR2820721105>3.0.CO;2-N","article-title":"Adrenal cortical carcinoma: Epidemiology and treatment with mitotane and a review of the literature","volume":"72","author":"Wooten","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.bioorg.2023.106835_b0010","first-page":"2017","article-title":"Childhood adrenocortical tumors","volume":"82","author":"Sandrini","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106835_b0015","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W","article-title":"Adrenocortical carcinoma: Clinical and laboratory observations","volume":"88","author":"Wajchenberg","year":"2000","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106835_b0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/pbc.20624","article-title":"Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil","volume":"47","author":"Pianovski","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"20","key":"10.1016\/j.bioorg.2023.106835_b0025","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1200\/JCO.2012.46.3711","article-title":"Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors","volume":"31","author":"Cust\u00f3dio","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106835_b0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/pbc.20318","article-title":"Biology, clinical characteristics, and management of adrenocortical tumors in children","volume":"45","author":"Rodriguez-Galindo","year":"2005","journal-title":"Pediatr. Blood Cancer"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106835_b0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0039-6060(96)80164-4","article-title":"The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group","volume":"119","author":"Crucitti","year":"1996","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.bioorg.2023.106835_b0040","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00268-001-0047-y","article-title":"Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons Study Group","volume":"25","author":"Icard","year":"2001","journal-title":"World J. Surg."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106835_b0045","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1634\/theoncologist.2016-0459","article-title":"Complete responses to mitotane in metastatic adrenocortical carcinoma\u2014A new look at an old drug","volume":"22","author":"Reidy-Lagunes","year":"2017","journal-title":"Oncologist"},{"issue":"23","key":"10.1016\/j.bioorg.2023.106835_b0050","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.3390\/cancers13236111","article-title":"Newborn screening for the detection of the TP53 R337H variant and surveillance for early diagnosis of pediatric adrenocortical tumors: Lessons learned and way forward","volume":"13","author":"Tosin","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2023.106835_b0055","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-53-4-672","article-title":"Chemotherapy of adrenocortical cancer with o, p\u2032-DDD","volume":"53","author":"Bergenstal","year":"1960","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106835_b0060","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1002\/1097-0142(197811)42:5<2177::AID-CNCR2820420514>3.0.CO;2-X","article-title":"O, p'-DDD (mitotane) therapy of adrenal cortical carcinoma: observations on drug dosage, toxicity, and steroid replacement","volume":"42","author":"Hogan","year":"1978","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.bioorg.2023.106835_b0065","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/bjc.1994.183","article-title":"Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients","volume":"69","author":"Haak","year":"1994","journal-title":"Braz. J. Cancer"},{"issue":"6","key":"10.1016\/j.bioorg.2023.106835_b0070","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/1097-0142(20010915)92:6<1385::AID-CNCR1461>3.0.CO;2-2","article-title":"Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o, p\u2032DDD) levels on the treatment of patients with adrenocortical carcinoma","volume":"92","author":"Baudin","year":"2001","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.bioorg.2023.106835_b0075","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1159::AID-CNCR28>3.0.CO;2-R","article-title":"Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study","volume":"88","author":"Williamson","year":"2000","journal-title":"Cancer"},{"issue":"02\/03","key":"10.1016\/j.bioorg.2023.106835_b0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/a-0715-1946","article-title":"Advanced adrenocortical carcinoma \u2013 what to do when first-line therapy fails?","volume":"127","author":"Megerle","year":"2019","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"3","key":"10.1016\/j.bioorg.2023.106835_b0085","doi-asserted-by":"crossref","first-page":"101415","DOI":"10.1016\/j.beem.2020.101415","article-title":"New perspectives for mitotane treatment of adrenocortical carcinoma","volume":"34","author":"Puglisi","year":"2020","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"23","key":"10.1016\/j.bioorg.2023.106835_b0090","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2023.106835_b0095","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1677\/erc.1.01025","article-title":"Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial","volume":"12","author":"Berruti","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bioorg.2023.106835_b0100","first-page":"47","article-title":"The treatment of adrenocortical carcinoma with o, p\u2019-DDD: prognostic implications of serum level monitoring","volume":"20","author":"Van-Slooten","year":"1984","journal-title":"Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106835_b0105","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.surg.2007.09.006","article-title":"Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma","volume":"142","author":"Gonzalez","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.bioorg.2023.106835_b0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0090-9556(25)00240-5","article-title":"Metabolism and covalent binding of 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane (o, p'-DDD). Correlation between adrenocorticolytic activity and metabolic activation by adrenocortical mitochondria","volume":"8","author":"Martz","year":"1980","journal-title":"Drug Metab. Dispos."},{"issue":"2-3","key":"10.1016\/j.bioorg.2023.106835_b0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0009-8981(87)90141-0","article-title":"Use of GC\/MS\/SIM for rapid determination of plasma levels of o, p'-DDD, o, p'-DDE and o, p'-DDA","volume":"170","author":"Inouye","year":"1987","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106835_b0120","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jps.2600840203","article-title":"Metabolic activation and binding of mitotane in adrenal cortex homogenates","volume":"84","author":"Cai","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2023.106835_b0125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00007691-199906000-00020","article-title":"Determination of mitotane (o-p\u2019-DDD) and its metabolites o-p\u2019-DDA and o-p\u2019-DDE in plasma by high-performance liquid chromatography","volume":"21","author":"Andersen","year":"1999","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106835_b0130","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1210\/jc.2010-2676","article-title":"Plasma concentrations of o, p'DDD, o, p'DDA, and o, p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study","volume":"96","author":"Hermsen","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"23","key":"10.1016\/j.bioorg.2023.106835_b0135","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jchromb.2011.06.001","article-title":"A simple HPLC method for plasma level monitoring of mitotane and its two main metabolites in adrenocortical cancer patients","volume":"879","author":"Garg","year":"2011","journal-title":"J. Chromatogr. B"},{"issue":"5","key":"10.1016\/j.bioorg.2023.106835_b0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/separations8050063","article-title":"Determination of mitotane (DDD) and principal metabolite by a simple HPLC-UV method and its validation in human plasma samples","volume":"8","author":"Luci","year":"2021","journal-title":"Separations"},{"issue":"7","key":"10.1016\/j.bioorg.2023.106835_b0145","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1111\/bcp.14721","article-title":"Pharmacological profile and effects of mitotane in adrenocortical carcinoma","volume":"87","author":"Corso","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106835_b0150","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/jps.2600631113","article-title":"Aromatic hydroxylation, and alkyl oxidation in the metabolism of mitotane (o, p'-DDD) in humans","volume":"63","author":"Reif","year":"1974","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.bioorg.2023.106835_b0155","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1590\/S0100-879X2000001000009","article-title":"Conventional and novel strategies in the treatment of adrenocortical cancer","volume":"33","author":"Schteingart","year":"2000","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106835_b0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2116\/analsci.13.75","article-title":"Identification of photodegradation products of DDT in water","volume":"13","author":"Hong","year":"1997","journal-title":"Anal. Sci."},{"key":"10.1016\/j.bioorg.2023.106835_b0165","first-page":"111","article-title":"Comparison of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry with electron ionization and negative-ion chemical ionization for analyses of pesticides at trace levels in atmospheric samples","volume":"3","author":"Fulton","year":"2008","journal-title":"Anal. Chem. Insights"},{"issue":"4","key":"10.1016\/j.bioorg.2023.106835_b0170","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1039\/c6pp00438e","article-title":"Absolute configuration determination through theunique intramolecular excitonic coupling in thecircular dichroisms of o, p\u2019-DDT and o, p\u2019-DDD a combined experimental and theoretical study","volume":"16","author":"Tanaka","year":"2017","journal-title":"Photochem. Photobiol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106835_b0175","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/tox.10069","article-title":"Determination of chiral ratio of o, p-DDT and o, p-DDD pesticides on polysaccharides chiral stationary phases by HPLC under reversed-phase mode","volume":"17","author":"Ali","year":"2002","journal-title":"Environ. Toxicol."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106835_b0180","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.chemosphere.2005.04.100","article-title":"Enantiomeric ratios as an indicator of exposure processes for persistent pollutants in human placentas","volume":"62","author":"Shen","year":"2006","journal-title":"Chemosphere"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106835_b0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.chemosphere.2009.03.050","article-title":"Interindividual differences in o, p\u2019-DDD enantiomer kinetics examined in G\u00f6ttingen minipigs","volume":"76","author":"Cantillana","year":"2009","journal-title":"Chemosphere"},{"issue":"12","key":"10.1016\/j.bioorg.2023.106835_b0190","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2217\/pgs.12.116","article-title":"Effects of mitotane on gene expression in the adrenocortical cell line NCI-H295R: a microarray study","volume":"13","author":"Zsippai","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.bioorg.2023.106835_b0195","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3892\/mmr.2012.1244","article-title":"The effect of mitotane on viability, steroidogenesis and gene expression in NCI-H295R adrenocortical cells","volume":"7","author":"Lehmann","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106835_b0200","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1210\/en.2015-1367","article-title":"Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells","volume":"156","author":"Sbiera","year":"2015","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.bioorg.2023.106835_b0205","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/00498250903470230","article-title":"Chiral effects in adrenocorticolytic action of o, p'-DDD (mitotane) in human adrenal cells","volume":"40","author":"Asp","year":"2010","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106835_b0210","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1871526517666170329123845","article-title":"Role of chirality in drugs: An overview","volume":"18","author":"Alkadi","year":"2018","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.bioorg.2023.106835_b0215","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1530\/EJE-10-0956","article-title":"Mitotane has a strong and a durable inducing effect on CYP3A4 activity","volume":"164","author":"Van-Erp","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bioorg.2023.106835_b0220","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/009841098159187","article-title":"Comparative pharmacodynamics of CYP2B induction by DDT, DDE, and DDD in male rat liver and cultured rat hepatocytes","volume":"53","author":"Nims","year":"1998","journal-title":"J. Toxic. Environ. Health A"},{"key":"10.1016\/j.bioorg.2023.106835_b0225","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3390\/ph15121486","article-title":"Effects of o, p\u2019-DDE, a mitotane metabolite, in an adrenocortical carcinoma cell line","volume":"15","author":"Bach","year":"2022","journal-title":"Pharmaceuticals"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823004960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823004960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:46:43Z","timestamp":1758617203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823004960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":45,"alternative-id":["S0045206823004960"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106835","relation":{},"ISSN":["0045-2068"],"issn-type":[{"type":"print","value":"0045-2068"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two-dimensional chromatography for enantiomeric analysis of mitotane and its metabolite o,p\u2032-DDA in patients with adrenocortical carcinoma indicates enantioselective metabolism","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106835"}}